Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve: If cleared, the drug would be the first for slowing cognitive decline, but critics say the data does not prove it works
https://ift.tt/3fWEWYl June 01, 2021 at 11:10AM https://ift.tt/1R552o9
No comments:
Post a Comment